gsk result, page-2

Hi tooluck,

I think you are totally right with your post.
GSK has exepted Relenza back as one of their imported products and will push this in the market place.

Like always analysts and brokers are again far behind with this story and have been taken by suprise to see the huge increase in relenza sales.

For those who follow the Tamiflu / Relenza and bird flu development the indicators where there, for all to see that Relenza sales would dramatically increase in the next few years.

Stil the market has not woken up as this share will be trading within 12 months at least double todays price imho.

And I say at least because the potential earnings for Relenza alone will once again suprise all those brokers and analysts who suppose to know it all.

I am a happy holder and believe that anything under a dollar is cheap as chips.

But I also believe that this will change rapidly in the near future.

The bots certainly LOVE this share for a reason.

Good luck

jojo